GO Term |
---|
peptidase activity |
heterocyclic compound binding |
endopeptidase activity |
exopeptidase activity |
tripeptidyl-peptidase activity |
actin binding |
carboxypeptidase activity |
metalloendopeptidase activity |
metallopeptidase activity |
calmodulin binding |
Position | Description |
---|---|
523 | Not glycosylated |
1225 | Not glycosylated |
Position | Description | PubMed ID | GlyTouCan ID | Source |
---|---|---|---|---|
38 | N-linked (GlcNAc...) asparagine |
|
||
54 | N-linked (GlcNAc...) asparagine |
|
||
74 | N-linked (GlcNAc...) asparagine |
|
||
103 | N-linked (GlcNAc...) asparagine |
|
||
111 | N-linked (GlcNAc...) asparagine |
|
||
121 | N-linked (GlcNAc...) asparagine |
|
||
140 | N-linked (GlcNAc...) asparagine |
|
||
146 | N-linked (GlcNAc...) asparagine | |||
160 | N-linked (GlcNAc...) asparagine |
|
||
318 | N-linked (GlcNAc...) asparagine |
|
Pathway Name | Organism |
---|---|
Metabolism of Angiotensinogen to Angiotensins | Homo sapiens |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:0060255 | rippling muscle disease 2 | |
DOID:0060257 | dyschromatosis symmetrica hereditaria | |
DOID:0060262 | gallbladder disease | |
DOID:0060295 | complement component 2 deficiency | |
DOID:0060297 | complement component 4a deficiency | |
DOID:0060298 | complement component 4b deficiency | |
DOID:0060299 | complement component 6 deficiency | |
DOID:0060300 | complement component 7 deficiency | |
DOID:0060301 | type I complement component 8 deficiency | |
DOID:0060302 | type II complement component 8 deficiency |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024